BRIDGEWATER, NJ / ACCESSWIRE / May 29, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in

Related Keywords

San Diego , California , United States , Tirth Patel , Tirtht Patel , Omniab Inc , Tharimmune Inc , International Convention , Company Presentation Theater , Nasdaq , Presentation Theater , One Partnering , Ihr Portfolio ,